A Phase I Study Investigating the Combination of the Ziftomenib, Venetoclax and Azacitidine in Pediatric Relapsed and Refractory Acute Leukemias
Clinical trial NCT06397027 · RECRUITING
Trial details
- NCT number
- NCT06397027
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-27
- Primary completion
- 2028-12-31
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.